Bioactive Heterocycles Containing Endocyclic N-hydroxy Groups

Overview

Journal Eur J Med Chem

Specialty Chemistry

Date 2014 Dec 4

PMID 25466924

Citations 10

Authors

Reshma Rani

Carlotta Granchi

Affiliations

Soon will be listed here.

Abstract

Drug-likeness rules consider N-O single bonds as "structural alerts" which should not be present in a perspective drug candidate. In most cases this concern is correct, since it is known that N-hydroxy metabolites of branded drugs produce reactive species that cause serious side effects. However, this dangerous reactivity of the N-OH species generally takes place when the nitrogen atom is not comprised in a cyclic moiety. In fact, the same type of metabolic behavior should not be expected when the nitrogen atom is included in the ring of an aromatic heterocyclic scaffold. Nevertheless, heterocycles bearing endocyclic N-hydroxy portions have so far been poorly studied as chemical classes that may provide new therapeutic agents. This review provides an overview of N-OH-containing heterocycles with reported bioactivities that may be considered as therapeutically relevant and, therefore, may extend the chemical space available for the future development of novel pharmaceuticals. A systematic treatment of the various chemical classes belonging to this particular family of molecules is described along with a discussion of the biological activities associated to the most important examples.

Citing Articles

Isolation and characterization of plant-derived exosome-like nanoparticles from Carica papaya L. fruit and their potential as anti-inflammatory agent.

Iriawati I, Vitasasti S, Rahmadian F, Barlian A PLoS One. 2024; 19(7):e0304335.

PMID: 38959219 PMC: 11221653. DOI: 10.1371/journal.pone.0304335.

Simple electrochemical synthesis of cyclic hydroxamic acids by reduction of nitroarenes.

Winter J, Luhr S, Hochadel K, Galvez-Vazquez M, Prenzel T, Schollmeyer D Chem Commun (Camb). 2024; 60(55):7065-7068.

PMID: 38904167 PMC: 11223186. DOI: 10.1039/d4cc02118e.

Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy.

Masci D, Puxeddu M, Silvestri R, La Regina G Molecules. 2024; 29(9).

PMID: 38731601 PMC: 11085455. DOI: 10.3390/molecules29092110.

Advances in the synthetic strategies of benzoxazoles using 2-aminophenol as a precursor: an up-to-date review.

Soni S, Sahiba N, Teli S, Teli P, Agarwal L, Agarwal S RSC Adv. 2023; 13(34):24093-24111.

PMID: 37577091 PMC: 10416314. DOI: 10.1039/d3ra03871h.

Simple and scalable electrosynthesis of 1-1-hydroxy-quinazolin-4-ones.

Koleda O, Prenzel T, Winter J, Hirohata T, Galvez-Vazquez M, Schollmeyer D Chem Sci. 2023; 14(10):2669-2675.

PMID: 36908965 PMC: 9993888. DOI: 10.1039/d3sc00266g.

References

Raether W, Enders B, Hofmann J, Schwannecke U, Seidenath H, Hanel H . Antimalarial activity of new floxacrine-related acridinedione derivatives: studies on blood schizontocidal action of potential candidates against P. berghei in mice and P. falciparum in vivo and in vitro. Parasitol Res. 1989; 75(8):619-26. DOI: 10.1007/BF00930959. View

Li W, Leet J, Ax H, Gustavson D, Brown D, Turner L . Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. I. Taxonomy, fermentation and biological activities. J Antibiot (Tokyo). 2003; 56(3):226-31. DOI: 10.7164/antibiotics.56.226. View

Schmidt L . Antimalarial properties of floxacrine, a dihydroacridinedione derivative. Antimicrob Agents Chemother. 1979; 16(4):475-85. PMC: 352885. DOI: 10.1128/AAC.16.4.475. View

GILLETTE J . Commentary. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactivity metabolites with changes in the incidence and severity of toxicity. Biochem Pharmacol. 1974; 23(20):2785-94. DOI: 10.1016/0006-2952(74)90052-5. View

Nicolaou K, Estrada A, Freestone G, Lee S, Alvarez-Mico X . New synthetic technology for the construction of N-hydroxyindoles and synthesis of nocathiacin I model systems. Tetrahedron. 2010; 63(27):6088-6114. PMC: 2896327. DOI: 10.1016/j.tet.2007.03.072. View

Naidu B, Sorenson M, Zhang Y, Kim O, Matiskella J, Wichtowski J . Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics. Bioorg Med Chem Lett. 2004; 14(22):5573-7. DOI: 10.1016/j.bmcl.2004.08.058. View

Antunes E, Beukes D, Kelly M, Samaai T, Barrows L, Marshall K . Cytotoxic pyrroloiminoquinones from four new species of South African latrunculid sponges. J Nat Prod. 2004; 67(8):1268-76. DOI: 10.1021/np034084b. View

Morrow B, Lee E, Taylor J, Elsworth J, Nye H, Roth R . (S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitization. J Pharmacol Exp Ther. 1997; 283(2):712-21. View

Banoglu E . Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr Drug Metab. 2001; 1(1):1-30. DOI: 10.2174/1389200003339234. View

10.

Tricklebank M, Bristow L, Hutson P, Leeson P, Rowley M, Saywell K . The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. Br J Pharmacol. 1994; 113(3):729-36. PMC: 1510413. DOI: 10.1111/j.1476-5381.1994.tb17054.x. View

11.

Xu L, Farthing A, Dropinski J, Meinke P, McCallum C, Hickey E . Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs. Bioorg Med Chem Lett. 2012; 23(1):366-9. DOI: 10.1016/j.bmcl.2012.10.065. View

12.

Saito R, Ghosh K, Harada K, Katoh A . Microbial growth-promotion activity of 3-hydroxymonoazine- and N-hydroxydiazine-type heterocycles. Yakugaku Zasshi. 2002; 122(9):703-5. DOI: 10.1248/yakushi.122.703. View

13.

Dunn R, Flanagan D, Martin L, Kerman L, Woods A, Camacho F . Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents. Eur J Pharmacol. 1992; 214(2-3):207-14. DOI: 10.1016/0014-2999(92)90120-s. View

14.

Leet J, Li W, Ax H, Matson J, Huang S, Huang R . Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. II. Isolation, characterization, and structure determination. J Antibiot (Tokyo). 2003; 56(3):232-42. DOI: 10.7164/antibiotics.56.232. View

15.

Davies J, Watkins J . Antagonism of synaptic and amino acid induced excitation in the cuneate nucleus of the cat by HA-966. Neuropharmacology. 1973; 12(7):637-40. DOI: 10.1016/0028-3908(73)90116-0. View

16.

Billamboz M, Bailly F, Lion C, Calmels C, Andreola M, Witvrouw M . 2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4. Eur J Med Chem. 2010; 46(2):535-46. DOI: 10.1016/j.ejmech.2010.11.033. View

17.

FOSTER A, Kemp J . HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site. J Neurosci. 1989; 9(6):2191-6. PMC: 6569716. View

18.

Hazeldine S, Pachaiyappan B, Steinbergs N, Nowotarski S, Hanson A, Casero Jr R . Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1. J Med Chem. 2012; 55(17):7378-91. PMC: 3482425. DOI: 10.1021/jm3002845. View

19.

Naidu B, Sorenson M, Matiskella J, Li W, Sausker J, Zhang Y . Synthesis and antibacterial activity of nocathiacin I analogues. Bioorg Med Chem Lett. 2006; 16(13):3545-9. DOI: 10.1016/j.bmcl.2006.03.079. View

20.

BISCOE T, Davies J, Dray A, Evans R, Martin M, Watkins J . D-alpha-aminoadipate, alpha, epsilon-diominopimelic acid and HA-966 as antagonists of amino acid-induced and synpatic excitation of mammalian spinal neurones in vivo. Brain Res. 1978; 148(2):543-8. DOI: 10.1016/0006-8993(78)90745-x. View